Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MY HYPER-CVAD in Relapsed/Refractory Adult ALL
NCT00801580Phase 2Unknown
- Sponsor
- Alma Mater Studiorum – Università di Bologna
- Start
- Mar 2008
- Primary completion
- Sep 2010
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in acute lymphoblastic leukemia (ALL), sponsored by Alma Mater Studiorum – Università di Bologna. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00801580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801580.